B. Vrugt et al., NEW INSIGHTS INTO THE PATHOGENESIS OF SEVERE CORTICOSTEROID-DEPENDENTASTHMA, Journal of allergy and clinical immunology, 98(5), 1996, pp. 22-26
Severe asthma is characterized by persistent T-cell activation, as dem
onstrated in both peripheral blood and bronchial mucosa. Endobronchial
biopsy specimens of patients with severe, corticosteroid-dependent as
thma revealed increased expression of CD25+ on mucosal T cells. Increa
sed immunoreactivity, for IL-5 further supports the evidence that the
inflammatory response is orchestrated by T-H2-type T cells. Peripheral
blood eosinophils and total serum IgE levels were increased in the ab
sence of allergen and despite optimal treatment. The chemokine IL-8 ma
y also be an aggravating factor in severe asthma; as well as being a p
otent chemotactic and activating factor for neutrophils, it may also b
e chemoattractant for eosinophils. We have recently detected increased
levels of free IL-8 in the peripheral blood of patients with chronic
severe asthma but not in healthy control subjects or in patients with
mild asthma, even after allergen challenge. In patients with severe as
thma there may be an imbalance between IL-8 production and the blockin
g capacity of IL-S autoantibodies. Higher levels of IL-8 complexed to
IgA autoantibody and increased numbers of activated T cells were also
found in patients with unstable asthma compared with patients who had
severe but stable disease. We conclude that IL-8 may provide an additi
onal marker of asthma severity and corticosteroid responsiveness.